THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Trexquant Investment LP's Holding History (CIK: 0001633445)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 182,490 Value ($000) $3,414 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 144,533 Value ($000) $2,110 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 156,930 Value ($000) $1,731 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 165,424 Value ($000) $1,477 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 151,083 Value ($000) $1,422 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 100,257 Value ($000) $808 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 33,522 Value ($000) $284 Avg Close $9.03 Range $8.13 - $10.44
Q4 2022
Shares 18,705 Value ($000) $210 Avg Close $10.51 Range $9.56 - $11.83
Q4 2021
Shares 20,729 Value ($000) $229 Avg Close $8.72 Range $7.30 - $11.24
Q3 2020
Shares 13,167 Value ($000) $195 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 11,126 Value ($000) $234 Avg Close $25.69 Range $20.17 - $31.35
Q3 2016
Shares 5,995 Value ($000) $217 Avg Close $27.84 Range $21.97 - $37.14
Q2 2016
Shares 12,056 Value ($000) $274 Avg Close $21.59 Range $15.00 - $24.76
Q3 2015
Shares 55,000 Value ($000) $604 Avg Close $12.73 Range $10.69 - $15.00